← Leaderboards
Hayley Affronti
Roswell Park Cancer Institute Corp
$278,317
Attributed
$278,317
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $76.3K · FY2016–20$100K$75K$50K$25K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$278,317 · 2
By mechanism
K00$218,249 · 1
F99$60,068 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Carl W Porter$5,047,582
- Dominic James Smiraglia$3,001,000
- Lakshmi Pendyala$2,646,119
- Maria L Avantaggiati$6,905,214
- Leigh Ellis$3,518,676
Others in their field
Top investigators on “Cytostatics”
- Carol Prives · Icahn School Of Medicine At Mount Sinai$7,301,629
- Jason A Koutcher · Sloan-Kettering Institute For Cancer Res$5,864,299
- Alex Toker · Beth Israel Deaconess Medical Center$5,837,252
- Razelle Kurzrock · University Of Texas Md Anderson Can Ctr$4,857,269
- Joan Massague · Sloan-Kettering Institute For Cancer Res$4,458,329
- Piotr Sicinski · Dana-Farber Cancer Inst$4,107,788
Research focus
CytostaticsData SetAffectAnabolismCytotoxicAlternative TherapiesAmericanBackBudgetsCancer EtiologyCancer TherapyAndrogensCarbonCareerCareer DevelopmentApoptosisCell LineCellsClinical Trials DesignCombined Modality TherapyCommon TreatmentComorbidityComprehensive Cancer CenterDependence
Grant awards (5)
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer$76,292
K00 · FY2020 · CA · contact PI
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer$72,208
K00 · FY2019 · CA · contact PI
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer$69,749
K00 · FY2018 · CA · contact PI
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer$29,518
F99 · FY2017 · CA · contact PI
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer$30,550
F99 · FY2016 · CA · contact PI